EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease

Meri Kalashyan, Krishnan Raghunathan, Haley Oller, Marie-Theres Bayer, Lissette Jimenez, Joseph T Roland, Elena Kolobova, Susan J Hagen, Jeffrey D Goldsmith, Mitchell D Shub, James R Goldenring, Izumi Kaji und 1 weitere

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci169234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Meri Kalashyan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Malabsorption Syndromes, Myosin Type V, Mucolipidoses. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, TKO Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malabsorption SyndromesMyosin Type VMucolipidosesEnterocytesMicrovilliMyosin Heavy ChainsHumans

Stichwörter der Autor:innen

Drug therapyEpithelial transport of ions and waterGastroenterologyGenetic diseases

Substanzen

Myosin Heavy ChainsMyosin Type V

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Congenital Enteropathy Program, Boston Children's Hospital, Boston, Massachusetts, USA.
  • PediCODE Consortium, as detailed in Supplemental Acknowledgments.
  • Section of Surgical Sciences and.
  • Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Surgery, Division of Surgical Sciences, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • TKO Foundation

Zitieren

APA

Kalashyan, M., Raghunathan, K., Oller, H., Bayer, M. T., Jimenez, L., Roland, J. T., Kolobova, E., Hagen, S. J., Goldsmith, J. D., Shub, M. D., Goldenring, J. R., Kaji, I., & Thiagarajah, J. R. (2023). Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci169234

Vancouver

Kalashyan M, Raghunathan K, Oller H, Bayer MT, Jimenez L, Roland JT, et al. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease. Journal of Clinical Investigation. 2023. doi:10.1172/jci169234

BibTeX
@article{Kalashyan2023,
  author = {Kalashyan, Meri and Raghunathan, Krishnan and Oller, Haley and Bayer, Marie-Theres and Jimenez, Lissette and Roland, Joseph T and Kolobova, Elena and Hagen, Susan J and Goldsmith, Jeffrey D and Shub, Mitchell D and Goldenring, James R and Kaji, Izumi and Thiagarajah, Jay R},
  title = {Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci169234}
}
Kostenlos starten →